Managing Director of Pharmagellan and Professor of the Practice at Tufts University, Frank S. David, MD, PhD

Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics interviews Frank S. David, MD, PhD, Managing Director of Pharmagellan and Professor of the Practice at Tufts University. The healthcare investing and development world and the pharmacoeconomics world have historically operated separately despite drug pricing being core to both worlds. In this episode, Mel and Frank contrast how models are used and built in their respective worlds of pharmacoeconomics and healthcare investing and development.